Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals
Abstract Background Vulvovaginal candidiasis (VVC), the second leading cause of genital infection in women of reproductive age, is caused by yeasts of the genus Candida. Treatment is usually empirical and performed with azoles, which have shown increasing ineffectiveness due to resistance from these...
Main Authors: | Aline Lorenzoni Paniágua, Amabel Fernandes Correia, Lívia Custódio Pereira, Bruna Maciel de Alencar, Fabiana Brandão Alves Silva, Rosane Mansan Almeida, Yanna Karla de Medeiros Nóbrega |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | BMC Complementary Medicine and Therapies |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12906-021-03405-z |
Similar Items
-
CANDIDA AURIS – EMERGING FUNGAL PATHOGEN
by: Dominika Grondalska, et al.
Published: (2017-04-01) -
Biofilm-forming fluconazole-resistant Candida auris causing vulvovaginal candidiasis in an immunocompetent patient: A case report
by: Lakshmi Krishnasamy, et al.
Published: (2021-01-01) -
Experimental Mouse Models of Disseminated Candida auris Infection
by: Hong Xin, et al.
Published: (2019-09-01) -
Candida auris: emergence and epidemiology of a highly pathogenic yeast
by: Paula Slomp Santos, et al.
Published: (2017-09-01) -
Candida auris: emergence and epidemiology of a highly pathogenic yeast
by: Paula Slomp Santos, et al.
Published: (2017-09-01)